Role of Adiponectin in Matching of Fetal and Placental Weight in Mothers with Type 1 Diabetes

  1. Scott M. Nelson, PhD MRCOG1,
  2. Dilys J. Freeman, PhD1,
  3. Naveed Sattar, PhD FRCP(Glasg) FRCPath1 and
  4. Robert S. Lindsay, PhD FRCP(Glasg)1
  1. 1Faculty of Medicine, University of Glasgow UK

    Abstract

    Objective: To assess the association of fetal hormones with placental growth and fetal:placental weight ratio (FPI) in pregnancies complicated by maternal diabetes.

    Research Design and Methods: Prospective study using umbilical venous blood samples taken at birth from 122 offspring of mothers with type 1 diabetes (OT1DM) and 46 controls.

    Results: Placental weight (p=0.009) and gestation-adjusted birthweight (p<0.001) were increased in OT1DM, but FPI was unaltered (p=0.33). Placental weight correlated with birthweight (p<0.001) and cord leptin (p<0.001) in controls and OT1DM, with further relationships to cord insulin, IGF-1, IGFBP-3, triceps and subscapular thickness in OT1DM. FPI was associated with adiponectin in both groups, even after adjustment for confounders.

    Conclusions: Placental and fetal growth show a parallel increase in mothers with type 1 diabetes. The possible role of adiponectin in matching of fetal and placental growth merits further study.

    Footnotes

      • Received November 19, 2007.
      • Accepted March 10, 2008.